Related Experiment Videos
Oncologists and clinical trials: the profit motive
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2006
Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
Health care management science·2000
Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
A rural cancer outreach program lowers patient care costs and benefits both the rural hospitals and sponsoring academic medical center.
The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association·1999
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Refined Continuous Risk Index for Accurately Predicting Outcomes of Patients With Chronic Lymphocytic Leukemia After Limited-Duration Therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: A Phase III Randomized Clinical Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026